$5.38
-0.01 (-0.19%)
Open$5.54
Previous Close$5.39
Day High$5.70
Day Low$5.35
52W High$5.84
52W Low$3.50
Volume—
Avg Volume132.3K
Market Cap109.89M
P/E Ratio—
EPS$-1.48
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+600.9% upside
Current
$5.38
$5.38
Target
$37.71
$37.71
$24.55
$37.71 avg
$48.03
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 23.69M | 23.13M | 22.16M |
| Net Income | 4.47M | 4.40M | 4.69M |
| Profit Margin | 18.9% | 19.1% | 21.2% |
| EBITDA | 8.95M | 8.70M | 7.31M |
| Free Cash Flow | 3.30M | 3.54M | 2.93M |
| Rev Growth | +11.0% | +7.8% | +15.1% |
| Debt/Equity | 0.08 | 0.09 | 0.09 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,364.73 | -3.76% | 50.2 | 1.34T |
| JNJ | Johnson & Johnson | $272.32 | -1.45% | 41.3 | 665.03B |
| MRK | Merck & Co. Inc. | $146.94 | -2.27% | 117.2 | 371.99B |
| PFE | Pfizer Inc. | $29.88 | -2.96% | 40.0 | 173.27B |
| BMY | Bristol-Myers Squibb Co | $63.13 | -1.65% | 13.8 | 128.00B |
| ZTS | Zoetis Inc | $82.11 | -7.95% | 12.3 | 32.24B |